{"a":[{"_":"Roche drops TCE for lupus, but hasn’t given up on autoimmune cell therapies","$":{"href":"/biotech/roche-drops-tce-lupus-hasnt-given-autoimmune-cell-therapies","hreflang":"en"}}]}

negativeT-cell engager (TCE)Negative

AI Analysis

Summary

Roche has discontinued development of a T-cell engager for lupus, though the company maintains an ongoing strategy for cell therapies in autoimmune diseases.

Outcome Details

Roche discontinued development of a T-cell engager for lupus treatment

Importance:3/10

Sentiment:

-0.30

cell therapyautoimmune diseaselupusprogram discontinuationT-cell engager

Related Companies

$RHHBY

Read the original article

Published by FierceBiotech on July 23, 2026 4:54 AM

Read Original